Insurance Plan Structure Limiting Dialysis Liability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Medical Plans face high liabilities for end-stage renal disease (ESRD) treatments, particularly kidney dialysis, which can exceed $1,000,000 per patient, leading to significant financial burdens on both the Plans and patients, due to lack of competition and leverage in the dialysis market, resulting in out-of-pocket expenses for individuals and small entities.
Innovation Solution
Implementing a medical insurance Plan structure that limits Plan responsibility to 125% of the Medicare-approved amount for dialysis services, supplementing Medicare Part B coverage, and prohibiting balance billing, ensuring patients are not charged excess out-of-pocket costs by preventing providers from billing beyond the Plan limits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If medical Plans cover dialysis services without cost limits, then patients receive necessary life-extending treatment, but Plans face excessive financial liability exceeding $1,000,000 per patient
Solution Approach 1:
The patent changes the payment parameter from unlimited coverage to a capped amount based on Medicare-approved rates. Specifically, it limits Plan liability to 125% of the Medicare-approved amount for dialysis services, transforming the financial parameter from unbounded to bounded while preserving patient access to treatment.
Solution Approach 2:
The patent introduces Medicare-approved payment rates as an intermediary standard to mediate between unlimited Plan liability and patient care needs. By anchoring the payment cap to Medicare rates (a recognized external standard), the patent creates a fair intermediary reference point that protects both Plans from excessive costs and patients from inadequate coverage.
2Quantity of substance
If Plans limit dialysis coverage to control costs, then Plan liability is reduced, but patients face out-of-pocket expenses and cannot afford treatment
Solution Approach 1:
The patent changes the payment parameter from limited coverage to a sufficient capped amount (125% of Medicare-approved rates) that fully covers treatment costs. This parameter adjustment ensures the cap is high enough to prevent patient out-of-pocket expenses while still providing Plan cost control.
Solution Approach 2:
The patent employs Medicare-approved rates as a pre-established, standardized pricing mechanism that eliminates the need for complex negotiation and billing processes. This standardized rate structure acts as a 'disposable' solution that quickly resolves payment issues without requiring ongoing administrative overhead or patient financial risk.
3Quantity of substance
If Plans negotiate reduced fees with dialysis providers, then Plan costs are reduced, but lack of market leverage prevents effective negotiation for individuals and small entities
Solution Approach 1:
The patent creates a universal payment standard (125% of Medicare-approved rates) that applies to all Plans regardless of size or market leverage. This universal cap mechanism allows small entities and individuals to access the same cost-control protection as large employers, eliminating the need for market leverage to achieve reasonable pricing.
Solution Approach 2:
The patent changes the cost parameter from market-negotiated rates (which favor large Plans) to a regulated cap based on Medicare rates. This parameter transformation equalizes the playing field by replacing market power dynamics with a standardized regulatory framework that benefits all Plans equally.
4Reliability
If Plans pay above Medicare-approved amounts to ensure patient care, then patient access is maintained, but Plan premiums increase significantly
Solution Approach 1:
The patent changes the payment parameter from above-Medicare rates to a precise cap at 125% of Medicare-approved amounts. This parameter adjustment maintains patient access (by ensuring adequate payment) while controlling premium costs (by establishing a clear upper bound that prevents excessive spending).
Data Source
AI summary
Systems and methods are provided to limit exposure of medical Plans to high liabilities for renal dialysis without exposing the insured patient to out-of-pocket liability while still allowing the patient to receive dialysis as they need it. In one embodiment, this goal is achieved by providing an ERISA medical insurance Plan structure that limits Plan responsibility to 125% of the Medicare approved amount for the services provided, and simultaneously supplements coverage of the patient under Medicare Part B. Because Medicare regulations prohibit providers from balance-billing patients subsequent to billing Medicare, the patient cannot be billed for amounts in excess of the Plan limits.